Durintechnologies
1 known investors
Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease. The diagnostic tests run in a CLIA-certified, CAP-accredited laboratory and target early detection, subtyping, and staging of neurodegenerative diseases.
Investors · 1
Frequently asked questions
- What does Durintechnologies do?
- Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease. The diagnostic tests run in a CLIA-certified, CAP-accredited laboratory and target early detection, subtyping, and staging of neurodegenerative diseases.
- Who are Durintechnologies's investors?
- Durintechnologies's investors include Foundation Venture Capital Group, LLC.